- Supported exchanges /
- NASDAQ /
- LSB.NASDAQ
LakeShore Biopharma Co., Ltd (LSB NASDAQ) stock market data APIs
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. The company's product pipeline includes YSJA, a conventional rabies vaccine which is in marketed stage; PIKA, a rabies vaccine which are in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic that is in phase I trials for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine that is in phase I trials; PIKA YS-HBV-002, an immune-therapy vaccine which is in IND preclinical trials for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine which are in preclinical trials. It operates in China, Singapore, the United States, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. The company was founded in 2002 and is based in Beijing, China.
LakeShore Biopharma Co., Ltd Financial Data Overview
2.55 | |
2.91 | |
- | |
2.95 | |
2.31 | |
2.31-11.2 | |
114 M | |
191 M | |
573 M | |
-1.34 | |
0.547 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
LakeShore Biopharma Co., Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 573 M
- EBITDA -315 903 072
- Earnings Per Share -0.57
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get LakeShore Biopharma Co., Ltd Earnings via APIs
- Latest Release 2024-08-15
- EPS/Forecast -0.58
Get LakeShore Biopharma Co., Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: